White & Case has expanded its capabilities in the life sciences and intellectual property (IP) sectors with the addition of Bethany Hills as a partner. Hills joins the firm’s global life sciences and health-care group and its intellectual property practice in New York, reinforcing the firm’s focus on regulatory and compliance-related legal matters.
With extensive experience in advising clients in the life sciences and health technology industries, Hills is well-versed in navigating US regulatory frameworks. Her expertise encompasses federal law regulatory regimes enforced by notable entities such as the Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), Office of Inspector General, Department of Justice, and the Federal Trade Commission (FTC). Her role involves conducting thorough risk assessments, developing operational procedures and compliance programs, and managing the intricacies of medical-legal-regulatory approval processes. She also offers guidance on structuring commercial arrangements to mitigate legal risks.
This strategic hiring reflects White & Case’s ongoing efforts to bolster its service offerings in the highly-regulated sectors of life sciences and health care, where regulatory compliance and adept handling of IP rights are critical for business success. For more information, visit the announcement made by the firm.
The move not only enhances the firm’s standing in the American market but also aligns with its broader strategic objectives in addressing the complex legal needs of clients operating in these specialized fields. More details on the appointment can be found in the Bloomberg Law report.